Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET

Mark Liu, Elisabeth Bel, Oliver Kornmann, Wendy Moore, Norihiro Kaneko, Steven Smith, Neil Martin, Robert Price, Steven Yancey, Marc Humbert

Open source

DOI: 10.1183/23120541.00419-2021
Published: 2022-01-21
Container: ERJ Open Research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00419-2021,
  title = {Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET},
  author = {Mark Liu and Elisabeth Bel and Oliver Kornmann and Wendy Moore and Norihiro Kaneko and Steven Smith and Neil Martin and Robert Price and Steven Yancey and Marc Humbert},
  year = {2022},
  journal = {ERJ Open Research},
  doi = {10.1183/23120541.00419-2021},
  url = {https://doi.org/10.1183/23120541.00419-2021}
}

RIS

TY  - JOUR
TI  - Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET
AU  - Mark Liu
AU  - Elisabeth Bel
AU  - Oliver Kornmann
AU  - Wendy Moore
AU  - Norihiro Kaneko
AU  - Steven Smith
AU  - Neil Martin
AU  - Robert Price
AU  - Steven Yancey
AU  - Marc Humbert
PY  - 2022
JO  - ERJ Open Research
DO  - 10.1183/23120541.00419-2021
UR  - https://doi.org/10.1183/23120541.00419-2021
ER  -

APA

Liu, M., Bel, E., Kornmann, O., Moore, W., Kaneko, N., Smith, S., Martin, N., Price, R., Yancey, S., & Humbert, M. (2022). Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET. ERJ Open Research. https://doi.org/10.1183/23120541.00419-2021

Source records

hal · retrieved 2026-09-26T02:44:53.456Z